Influence of Heterologously Expressed azurin from Pseudomonas aeruginosa on the Adhesion and Invasion of Pathogenic Bacteria to the Caco-2 Cell Line.


Journal

Probiotics and antimicrobial proteins
ISSN: 1867-1314
Titre abrégé: Probiotics Antimicrob Proteins
Pays: United States
ID NLM: 101484100

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 1 8 2019
medline: 8 7 2021
entrez: 1 8 2019
Statut: ppublish

Résumé

This study proposed to investigate the effect of azurin on the major stages of pathogenesis (adhesion and invasion) of intestinal bacterial pathogens (Salmonella spp. and Escherichia coli) and epithelial pathogens (Staphylococcus aureus and Pseudomonas aeruginosa) on the human colorectal adenocarcinoma (Caco-2) cell line. Azurin protein was produced by cloning the azurin gene into pET21a and heterologous expression in E. coli BL21. The protein was purified using affinity chromatography and confirmed by Western blotting. The purified protein was evaluated by three experiments of adhesion and invasion assays, including exclusion, competition, and replacement. Azurin was observed to significantly inhibit the attachment and invasion of S. aureus, Salmonella spp., and E. coli, while no such inhibitory effects were observed on P. aeruginosa. In fact, the protein increased the adhesion of P. aeruginosa to the cell. In conclusion, our study proposes that azurin is a potential prophylactic or preventive helper candidate to inhibit the attachment and invasion of pathogenic bacteria to host cells and reduce the progression of the infection process. Our study also reveals the involvement of azurin in bacteria-host cell interactions, providing novel and important insights toward the elucidation of its biological function in this field. Thus, this study provides new opportunities to use azurin as an adjunct therapy against critical stages of infection by a wide range of pathogenic bacteria.

Identifiants

pubmed: 31364004
doi: 10.1007/s12602-019-09573-2
pii: 10.1007/s12602-019-09573-2
doi:

Substances chimiques

Azurin 12284-43-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

697-704

Auteurs

Hajar Mohammadi Barzelighi (HM)

Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Bahram Nasr Esfahani (BN)

Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Bita Bakhshi (B)

Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Bahram Daraei (B)

Department of Toxicology and Pharmacology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Sharareh Moghim (S)

Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Hossein Fazeli (H)

Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. h_fazeli@med.mui.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH